المؤلفون: Talal Ashour, Sami Azar, Akram Echtay, Muhammad Farooqi, Tarek Fiad, Mohamed Hassanein, Ahmed Hassoun, Abdul Jabbar, Amin Jayyousi, Kari Ranta, Hani Sabbour, Fatih Tangi, Ibrahim Turfanda

المصدر: Dubai Diabetes and Endocrinology Journal, Pp 1-11 (2023)

مصطلحات موضوعية: cardiovascular outcomes trials, cardiovascular risk, dulaglutide, glucagon-like peptide-1 receptor agonists, gulf and levant, primary prevention, rewind, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://beta.karger.com/Article/FullText/534713Test; https://doaj.org/toc/2673-1738Test

الوصول الحر: https://doaj.org/article/716fdb93783548ef97d665013e406f57Test

المؤلفون: Tianyu Wang, Juncan Ding, Xinyi Cheng, Qiang Yang, Pengfei Hu

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonists, atherosclerosis, cardiovascular outcome trials, inflammation, mitochondrial dysfunction, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2024.1396656/fullTest; https://doaj.org/toc/1663-9812Test

الوصول الحر: https://doaj.org/article/3555eae17c6a4774b69bffa5a0871207Test

المؤلفون: Joana Freitas, José Silvano, Catarina Ribeiro, Jorge Malheiro, Sofia Pedroso, Manuela Almeida, Isabel Fonseca, La Salete Martins

المصدر: Brazilian Journal of Transplantation, Vol 27 (2024)

مصطلحات موضوعية: Glucagon-like Peptide-1 Receptor Agonists, Kidney Transplant, Diabetes Mellitus, Specialties of internal medicine, RC581-951, Special situations and conditions, RC952-1245, Surgery, RD1-811

وصف الملف: electronic resource

العلاقة: https://bjt.emnuvens.com.br/revista/article/view/563Test; https://doaj.org/toc/2764-1589Test

الوصول الحر: https://doaj.org/article/8a1bd89554d04454af33627483c91aefTest

المؤلفون: Qingyue Zeng, Jiao Xu, Xingyu Mu, Yi Shi, Hong Fan, Shuangqing Li

المصدر: Frontiers in Endocrinology, Vol 15 (2024)

مصطلحات موضوعية: dual agonists, incretin based therapy, tirzepatide, type 2 diabetes, obesity, glucagon-like peptide-1 receptor agonists, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2024.1342543/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/2162f9c4b2ee436eaf8b18081da08edaTest

المؤلفون: Yongru Chen, Jingxian Chen, Shuo Zhang, Dan Zhu, Feiying Deng, Rui Zuo, Yufei Hu, Yue Zhao, Yale Duan, Benwei Lin, Fengwu Chen, Yun Liang, Jiaxiong Zheng, Barkat Ali Khan, Kaijian Hou

المصدر: Frontiers in Pharmacology, Vol 15 (2024)

مصطلحات موضوعية: type 2 diabetes, time in range, glucagon-like peptide-1 receptor agonists, continuous glucose monitoring, oral antidiabetic drugs, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2024.1370594/fullTest; https://doaj.org/toc/1663-9812Test

الوصول الحر: https://doaj.org/article/283ccd79bcdc4c0bb6e6bfbc3706d7a4Test

المؤلفون: José M. Rodriguez‐Valadez, Malak Tahsin, Umesh Masharani, Meyeon Park, M. G. Myriam Hunink, Joseph Yeboah, Lihua Li, Ellerie Weber, Asem Berkalieva, Luuk Avezaat, Wendy Max, Kirsten E. Fleischmann, Bart S. Ferket

المصدر: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)

مصطلحات موضوعية: cardiovascular disease, glucagon‐like peptide‐1 receptor agonists, kidney failure, meta‐analysis, meta‐regression, randomized trials, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2047-9980Test

الوصول الحر: https://doaj.org/article/78b10788b725414dbbab332b1f6a1ac1Test

المؤلفون: Wei Chen, Peishan Cai, Wenbin Zou, Zhiwen Fu

المصدر: Frontiers in Endocrinology, Vol 15 (2024)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonists, psychiatric adverse events, disproportionality analyses, FAERS database, pharmacovigilance study, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2024.1330936/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/d196a59092bd48b69bc81980cd4509b0Test

المؤلفون: Cesta, Carolyn E., Rotem, Ran, Bateman, Brian T., Chodick, Gabriel, Cohen, Jacqueline M., Furu, Kari, Gissler, Mika, Huybrechts, Krista F., Kjerpeseth, Lars J., Leinonen, Maarit K., Pazzagli, Laura, Zoega, Helga, Seely, Ellen W., Patorno, Elisabetta, Hernández-Díaz, Sonia

المساهمون: Faculty of Medicine

مصطلحات موضوعية: Cohort Studies, Diabetes Mellitus, Type 2/drug therapy, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Female, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Hypoglycemic Agents/adverse effects, Insulin/adverse effects, Pregnancy, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sulfonylurea Compounds/adverse effects, Internal Medicine

وصف الملف: 144-152

العلاقة: JAMA Internal Medicine; 184(2); http://www.scopus.com/inward/record.url?scp=85181034956&partnerID=8YFLogxKTest; Cesta , C E , Rotem , R , Bateman , B T , Chodick , G , Cohen , J M , Furu , K , Gissler , M , Huybrechts , K F , Kjerpeseth , L J , Leinonen , M K , Pazzagli , L , Zoega , H , Seely , E W , Patorno , E & Hernández-Díaz , S 2024 , ' Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy ' , JAMA Internal Medicine , vol. 184 , no. 2 , pp. 144-152 . https://doi.org/10.1001/jamainternmed.2023.6663Test; 215155202; 198ef4fd-ee4e-4302-b551-12e929142bad; 85181034956; https://hdl.handle.net/20.500.11815/4806Test

الإتاحة: https://doi.org/20.500.11815/4806Test
https://doi.org/10.1001/jamainternmed.2023.6663Test
https://hdl.handle.net/20.500.11815/4806Test

المؤلفون: Scheen, André, Paquot, Nicolas, Lancellotti, Patrizio

المصدر: Revue Médicale de Liège, 79 (4), 260-264 (2024-04)

مصطلحات موضوعية: Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor, Humans, Diabetes Mellitus, Type 2/complications/drug therapy, Hypoglycemic Agents/therapeutic use, Cardiovascular System, Heart Failure/complications, Coronary Artery Disease/complications, Glucagon-Like Peptide-1 Receptor/agonists, Cardiovascular Diseases/complications, GLP-1 receptor agonist, Gliflozin, Heart failure, Myocardial Infarction, SGLT2 inhibitor, Type 2 diabetes, Human health sciences, Cardiovascular & respiratory systems, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire

العلاقة: urn:issn:0370-629X; urn:issn:2566-1566

الوصول الحر: https://orbi.uliege.be/handle/2268/316759Test

المؤلفون: Tomasz Tabernacki, Lindsey Wang, David C. Kaelber, Rong Xu, Nathan A. Berger

المصدر: Cancers, Vol 16, Iss 13, p 2377 (2024)

مصطلحات موضوعية: lung cancer, type 2 diabetes mellitus, insulin therapy, non-insulin antidiabetic agents, glucagon-like peptide-1 receptor agonists, cancer risk reduction, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/16/13/2377Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/6483a44757a74d5682f813af04d31aa3Test